AllianceBernstein’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-631,303
| Closed | -$15.1M | – | 3531 |
|
|
2021
Q1 | $15.1M | Buy |
631,303
+554,903
| +726% | +$10.3M | 0.01% | 1025 |
|
|
2020
Q4 | $1.11M | Hold |
76,400
| – | – | ﹤0.01% | 2246 |
|
|
2020
Q3 | $1.08M | Buy |
76,400
+6,500
| +9% | +$99.3K | ﹤0.01% | 2147 |
|
|
2020
Q2 | $1.03M | Sell |
69,900
-14,300
| -17% | -$145K | ﹤0.01% | 2189 |
|
|
2020
Q1 | $347K | Buy |
84,200
+18,900
| +29% | +$88.6K | ﹤0.01% | 2540 |
|
|
2019
Q4 | $314K | Hold |
65,300
| – | – | ﹤0.01% | 2759 |
|
|
2019
Q3 | $396K | Hold |
65,300
| – | – | ﹤0.01% | 2677 |
|
|
2019
Q2 | $424K | Buy |
65,300
+5,000
| +8% | +$35.2K | ﹤0.01% | 2683 |
|
|
2019
Q1 | $428K | Buy |
60,300
+4,500
| +8% | +$29.6K | ﹤0.01% | 2587 |
|
|
2018
Q4 | $271K | Hold |
55,800
| – | – | ﹤0.01% | 2776 |
|
|
2018
Q3 | $410K | Hold |
55,800
| – | – | ﹤0.01% | 2705 |
|
|
2018
Q2 | $356K | Buy |
55,800
+6,500
| +13% | +$43K | ﹤0.01% | 2746 |
|
|
2018
Q1 | $268K | Hold |
49,300
| – | – | ﹤0.01% | 2736 |
|
|
2017
Q4 | $206K | Hold |
49,300
| – | – | ﹤0.01% | 2857 |
|
|
2017
Q3 | $475K | Sell |
49,300
-3,800
| -7% | -$39.5K | ﹤0.01% | 2590 |
|
|
2017
Q2 | $628K | Hold |
53,100
| – | – | ﹤0.01% | 2525 |
|
|
2017
Q1 | $681K | Sell |
53,100
-3,000
| -5% | -$36.1K | ﹤0.01% | 2421 |
|
|
2016
Q4 | $687K | Hold |
56,100
| – | – | ﹤0.01% | 2436 |
|
|
2016
Q3 | $662K | Hold |
56,100
| – | – | ﹤0.01% | 2411 |
|
|
2016
Q2 | $488K | Buy |
56,100
+2,300
| +4% | +$15.8K | ﹤0.01% | 2527 |
|
|
2016
Q1 | $284K | Sell |
53,800
-2,500
| -4% | -$13.9K | ﹤0.01% | 2614 |
|
|
2015
Q4 | $437K | Hold |
56,300
| – | – | ﹤0.01% | 2497 |
|
|
2015
Q3 | $443K | Hold |
56,300
| – | – | ﹤0.01% | 2528 |
|
|
2015
Q2 | $510K | Sell |
56,300
-1,900
| -3% | -$19.2K | ﹤0.01% | 2581 |
|
|
2015
Q1 | $755K | Hold |
58,200
| – | – | ﹤0.01% | 2326 |
|
|
2014
Q4 | $792K | Hold |
58,200
| – | – | ﹤0.01% | 2327 |
|
|
2014
Q3 | $522K | Hold |
58,200
| – | – | ﹤0.01% | 2496 |
|
|
2014
Q2 | $787K | Buy |
58,200
+22,277
| +62% | +$232K | ﹤0.01% | 2368 |
|
|
2014
Q1 | $357K | Hold |
35,923
| – | – | ﹤0.01% | 2547 |
|
|
2013
Q4 | $478K | Buy |
35,923
+12,500
| +53% | +$152K | ﹤0.01% | 2465 |
|
|
2013
Q3 | $285K | Sell |
23,423
-653
| -3% | -$7K | ﹤0.01% | 2748 |
|
|
2013
Q2 | $249K | Buy |
+24,076
| New | +$332K | ﹤0.01% | 2774 |
|
AllianceBernstein's GNMK Position: Q2 2021 in Review
AllianceBernstein sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 631,303 shares — an estimated $15.1M sold.
AllianceBernstein first reported a position in GNMK in Q2 2013 and held it in 32 quarters. The position peaked at $15.1M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- AllianceBernstein reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- AllianceBernstein sold 631,303 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $15.1M.
- AllianceBernstein first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 32 quarters.
- AllianceBernstein's GenMark Diagnostics, Inc position peaked at $15.1M in Q1 2021.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on AllianceBernstein's 13F filing for Q2 2021, filed 30 Jul 2021.